Towards a Medicines Transparency Alliance MeTA

1
Towards a Medicines Transparency Alliance (MeTA)

• Daniel Graymore (d-graymore_at_dfid.gov.uk)
• MeTA Expert Consultation Meeting 13 March

2
Medicines Transparency Alliance

• Intended to increase access to quality medicines
• Transparency in medicines procurement and supply
  in public and private sectors from port to
  patient
• Accounting and accountability
• Country led
• Multistakeholder
• White Paper 3 commitment

3
Problem

• Excessive mark-ups
• Fraud and corruption
• Poor management

4
Example complexity of medicines supply in Kenya
Source SSDS Inc for the World Bank
5
How does transparency help?

• Puts good data in the public domain
• Enables scrutiny of the supply chain
• Facilitates responsible business practice
• Helps achieve better value for money in
  procurement
• Empowers patients / consumers
• Creates enabling space for policy dialogue
• Contributes to better use of Govt and aid
  resources

6
The MeTA Proposal

• Secure high level political commitment
• Broker agreement amongst government and the
  private sector to disclose price, quantity and
  quality data into the public domain.
• Do this through a multi-stakeholder approach -
  government, civil society, industry.
• Place particular emphasis on the role of civil
  society in the design of the initiative and the
  dissemination and use of the results.
• Support all of this with political, technical and
  financial support from the international
  community

7
Lessons from the Extractive Industries
Transparency Initiative

• Multistakeholder gov., private sector, NGOs and
  others to increase transparency over payments
  made by oil, gas and mining companies to host
  governments in countries of operation.
• Launched in 2002 (Piloted during 2003 and 2004)
• G8 support since 2003, Commission for Africa,
  individual governments
• 26 countries now implementing
• Recent Oslo conference launched governance and
  validation
• Three key strengths
• multi-stakeholder
• accounting issues are matched with accountability
• clear and narrow focus

8
International Community
Multistakeholder group International
commitment Financial, technical and political
support
WB
WHO
Other initiatives at the country level
Donors
Scoping exercise Political commitment Multi-stak
eholder group Baseline report Standardised
disclosure Public reports
MeTA
Private sector
Civil society
9
International Community
Multistakeholder group International
commitment Financial, technical and political
support
Scoping exercise Political commitment Multi-stak
eholder group Baseline report Standardised
disclosure Public reports
MeTA
Pricing surveys
Observatory
Procurement support
Regulatory support
10
Incentives
Pharmaceutical companies (generic and
patent) Accurate information on pricing Proactive
role Improved procurement, inc. forecasting
(virtuous circle) Achieve public health
objectives Reduce pressure for inappropriate
behaviour
Support and commitment from international
community Improved procurement and supply Better
public health outcomes Commitment to tackle
corruption Commitment to financial probity and
good governance
Gov
Increased information Place at the
table Supportive environment for
advocacy Financial and other support Improved
dialogue with public and private sectors
Civil society
Private sector
Wholesales, distributors, retailers New support
for building capacity Improved market
operation Tackle corruption and wasteful
practices
Int. institutions
Donors
Good governance agenda Tackle corruption Increase
access to medicines Support responsible
business Fiduciary duty on aid exp.
Advance good governance agenda Promote ethical
pharma procuement and supply Improve health
outcomes
11
Progress and next steps

• Consultation developing country governments,
  international institutions, pharmaceutical
  industry, donors, NGOs
• Positive response
• Country visits
• Planned series of consultation meetings
  pharmaceutical industry, procurement and supply
  and demand
• SoS hosted stakeholder meeting April 18
• Develop a multistakeholder forum at the
  international level
• Launch 6 pilots to run for 9 12 months
• Full launch in 2008